Evidence map›Paper›PMID 40921948›Full record

ArticleJournal of ultrasound2025

Ibrutinib-associated hematoma of the liver: role of ultrasound in diagnosis and clinical management.

Rosa Buonamassa, Emilia Cappello, Angela Di Matteo, Marcello Maestri, Sofia Frattola, Enrico Brunetti

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of ultrasound, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rosa BuonamassaDepartment of Internal Medicine and Medical Therapy, University of Pavia (UniPV), Pavia, Italy. rosa.buonamassa01@universitadipavia.it.ORCID http://orcid.org/0009-0001-0103-6609
Emilia CappelloDepartment of Internal Medicine and Medical Therapy, University of Pavia (UniPV), Pavia, Italy.
Angela Di MatteoDivision of Infectious and Tropical Diseases, IRCCS S. Matteo Hospital Foundation, Pavia, Italy.
Marcello MaestriDivision of General Surgery 1, Department of Surgery, Fondazione IRCCS Policlinico San Matteo, 27100, Pavia, Italy.
Sofia FrattolaDepartment of Internal Medicine and Medical Therapy, University of Pavia (UniPV), Pavia, Italy.
Enrico BrunettiDepartment of Internal Medicine and Medical Therapy, University of Pavia (UniPV), Pavia, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ibrutinib, a Bruton's tyrosine kinase (BTK) inhibitor, has transformed the management of mantle cell lymphoma (MCL) but is associated with an elevated risk of bleeding. We report a rare case of hepatic subcapsular hematoma due to ibrutinib in a patient with relapsed MCL. Ultrasound was crucial in the early detection, monitoring, and management of this rare but potentially severe complication.

Indexed as

Hepatic hematomaIbrutinibUltrasound

Identifiers

PMID40921948

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.